These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18629387)

  • 1. A Canadian context for the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF) trial.
    Armstrong PW; Rouleau JL
    Can J Cardiol; 2008 Jul; 24 Suppl B(Suppl B):30B-2B. PubMed ID: 18629387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with B-type natriuretic peptide for chronic decompensated heart failure: insights learned from the follow-up serial infusion of nesiritide (FUSION) trial.
    Yancy CW
    Heart Fail Rev; 2004 Jul; 9(3):209-16. PubMed ID: 15809819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
    Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
    Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models.
    Khazanie P; Heizer GM; Hasselblad V; Armstrong PW; Califf RM; Ezekowitz J; Dickstein K; Levy WC; McMurray JJ; Metra M; Tang WH; Teerlink JR; Voors AA; O'Connor CM; Hernandez AF; Starling R
    Am Heart J; 2015 Aug; 170(2):290-7. PubMed ID: 26299226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.
    Greene SJ; Hernandez AF; Dunning A; Ambrosy AP; Armstrong PW; Butler J; Cerbin LP; Coles A; Ezekowitz JA; Metra M; Starling RC; Teerlink JR; Voors AA; O'Connor CM; Mentz RJ
    J Am Coll Cardiol; 2017 Jun; 69(25):3029-3039. PubMed ID: 28641792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
    Grodin JL; Perez AL; Wu Y; Hernandez AF; Butler J; Metra M; Felker GM; Voors AA; McMurray JJ; Armstrong PW; Califf RM; Starling RC; O'Connor CM; Tang WH
    JACC Heart Fail; 2015 Oct; 3(10):777-85. PubMed ID: 26449997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nesiritide: the clinical experience.
    Weeks SG
    Can J Cardiol; 2008 Jul; 24 Suppl B(Suppl B):19B-21B. PubMed ID: 18629384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
    Greene SJ; Hernandez AF; Sun JL; Metra M; Butler J; Ambrosy AP; Ezekowitz JA; Starling RC; Teerlink JR; Schulte PJ; Voors AA; Armstrong PW; O'Connor CM; Mentz RJ
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
    Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
    J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow.
    Ezekowitz JA; Hernandez AF; O'Connor CM; Starling RC; Proulx G; Weiss MH; Bakal JA; Califf RM; McMurray JJ; Armstrong PW
    J Am Coll Cardiol; 2012 Apr; 59(16):1441-8. PubMed ID: 22497823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF).
    Kelly JP; Mentz RJ; Hasselblad V; Ezekowitz JA; Armstrong PW; Zannad F; Felker GM; Califf RM; O'Connor CM; Hernandez AF
    Am Heart J; 2015 Aug; 170(2):298-305. PubMed ID: 26299227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nesiritide: a review of its use in acute decompensated heart failure.
    Keating GM; Goa KL
    Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF.
    Verma AK; Sun JL; Hernandez A; Teerlink JR; Schulte PJ; Ezekowitz J; Voors A; Starling R; Armstrong P; O'Conner CM; Mentz RJ
    Clin Cardiol; 2018 Jul; 41(7):945-952. PubMed ID: 29781109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nesiritide for the treatment of decompensated heart failure.
    Wylie JV; Tsao L
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):803-13. PubMed ID: 15500426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute study of clinical effectiveness of nesiritide in decompensated heart failure: nesiritide redux.
    Pleister AP; Baliga RR; Haas GJ
    Curr Heart Fail Rep; 2011 Sep; 8(3):226-32. PubMed ID: 21695395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure.
    Dandamudi S; Chen HH
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):557-63. PubMed ID: 22651831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure.
    Butler J; Emerman C; Peacock WF; Mathur VS; Young JB;
    Nephrol Dial Transplant; 2004 Feb; 19(2):391-9. PubMed ID: 14736964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Implications of Changes in Amino-Terminal Pro-B-Type Natriuretic Peptide in Acute Decompensated Heart Failure: Insights From ASCEND-HF.
    Grodin JL; Liebo MJ; Butler J; Metra M; Felker GM; Hernandez AF; Voors AA; McMurray JJ; Armstrong PW; O'Connor C; Starling RC; Troughton RW; Tang WHW
    J Card Fail; 2019 Sep; 25(9):703-711. PubMed ID: 30953792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
    Munger MA; Ng TM; Van Tassell BW
    Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.